Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07040163 · ClinicalTrials.gov registry record · Early Phase 1
Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology
A Early Phase 1 study of Sedation and Interventional Radiology, sponsored by CAMC Health System.
- Active
- Registry status
- Early Phase 1
- Development phase
- 276
- Enrollment target
- 1
- Study location
NCT07040163 is a Early Phase 1 study of Sedation and Interventional Radiology that is active but no longer recruiting, run by CAMC Health System. The registered enrollment target is 276 participants, below the 100,163-participant average among 12 other Sedation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07040163, a Early Phase 1 study of Sedation and Interventional Radiology, is active but no longer recruiting, sponsored by CAMC Health System.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 276 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to reduce pain during interventional radiology (IR) procedures, making the experience better for patients. Typically, doctors use medications like fentanyl and midazolam for sedation. This research will focus on patients undergoing biopsies and drainage procedures, often associated with significant discomfort. Patients will be randomly assigned to receive either fentanyl/midazolam or ketamine/midazolam combinations for sedation. A coordinator will collect information on pain levels and satisfaction, as well as monitor any extra medications needed and side effects. The investigators hope to find that ketamine helps decrease pain and improves satisfaction compared to fentanyl, without increasing complications.
Conditions Studied
Interventions
- DRUG Midazolam
- DRUG fentanyl
- DRUG ketamine
Study Locations (1)
West Virginia
- CAMC Memorial - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2025-03-07 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07040163
The ClinicalTrials.gov registry entry for NCT07040163 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 100,163-participant average among 12 other Sedation trials with a reported enrollment target (100% lower). The listed sponsor is CAMC Health System, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Sedation appearing as the primary indexed condition, and to 3 interventions - of which Midazolam is the first listed.
NCT07040163 reports 1 study location spanning 1 distinct geographic area - top geographies include West Virginia.
Frequently Asked Questions
What is clinical trial NCT07040163 about?
NCT07040163 is a clinical study titled "Evaluation of Ketamine/Midazolam Sedation vs. Fentanyl/Midazolam Sedation for Image-Guided Percutaneous Procedures in Interventional Radiology". This study aims to reduce pain during interventional radiology (IR) procedures, making the experience better for patients. Typically, doctors use medications like fentanyl and midazolam for sedation. This research will focus on patients undergoing biopsies and drainage procedures, often associated w...
What is the current status of trial NCT07040163?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 276 participants. The study started on 2025-03-07. Estimated completion is 2026-06.
What conditions does trial NCT07040163 study?
This clinical trial studies the following conditions: Sedation, Interventional Radiology, Biopsy, Drainage Procedure.
What interventions are being tested in trial NCT07040163?
The interventions under investigation include: Midazolam (DRUG), fentanyl (DRUG), ketamine (DRUG).
Who is sponsoring clinical trial NCT07040163?
This trial is sponsored by CAMC Health System, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07040163 being conducted?
This trial has 1 study location across West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sedation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Oral vs IV Sedation for Cataract Surgery in Older Adults
RECRUITING · Phase 4
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes
RECRUITING
-
A Pooled Analysis of Long-Term Outcomes After Inhaled Isoflurane Via the Sedaconda ACD-S Compared to Intravenous Propofol
ACTIVE NOT RECRUITING · Phase 3
-
Efficacy and Safety of Inhaled Isoflurane Delivered Via the Sedaconda ACD-S Compared to Intravenous Propofol for Sedation of Mechanically Ventilated Intensive Care Unit Adult Patients (INSPiRE-ICU1)
ACTIVE NOT RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.